House committee chairman calls for overhaul of PhilHealth leadership
The chairman of the House Committee on Public Accounts Saturday called for an “overhaul” in the leadership of the Philippine Medical Insurance Corporation (PhilHealth) amid new accusations of corruption that have implicated certain officials.

Anakalusugan Rep. Michael Defensor aired this recommendation as squabbling former and incumbent PhilHealth officials are set to meet face-to-face when the public accounts panel meet for a hearing that will be conducted after the State of the Nation Address on Monday, July 27.
Defensor noted that PhilHealth had been the object of various legislative inquiries over reports of alleged corruption implicating former and incumbent officials.
“When there seems to be a pattern of alleged abuses where loopholes can be taken advantage of by the unscrupulous, a systemic change needs to be done to overhaul the present setup,” said the administration lawmaker.
Defensor said PhilHealth CEO Ricardo Morales and his outspoken critic, lawyer Thomson Montes Keith, will be invited to the hearings of a moto-propio investigation on the issues raised in the media.
The panel chairman said various news sources have come out with an account of an alleged shouting match among PhilHealth officials during a virtual executive meeting.
The officials reportedly exchanged accusations, prompting the resignation of “several personalities.”
In a still unnumbered resolution, Defensor said Keith was among those who resigned in protest of the alleged withholding of his salary.
In his resignation letter, Keith said he no longer received his salary when he started “investigating PhilHealth officers allegedly involved in corruption.”
Defensor recalled that in June, 2019, Presidential Spokesman Harry Roque openly chided the agency for its supposed inaction into reports that at least P154 billion of its funds disappeared.
In August,2019, the Commission on Audit called out PhilHealth for questionable claims made by members for pneumonia, acute gastroenteritis, urinary tract infection, sepsis and other diseases.
According to Defensor the Senate Blue Ribbon Committee investigated in 2015 the surge in benefit reimbursements for cataract removal.